"
Team:Paris Bettencourt
From 2013.igem.org
(Difference between revisions)
| Line 105: | Line 105: | ||
z-index:1; | z-index:1; | ||
position:relative; | position:relative; | ||
| - | bottom: | + | bottom:350px; |
background:transparent; | background:transparent; | ||
} | } | ||
| Line 277: | Line 277: | ||
<a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/Results" title="Results"> | <a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/Results" title="Results"> | ||
<div class="subpanel3" > | <div class="subpanel3" > | ||
| - | <img width="70px" style="margin-left:120px;margin-right:15px;position:relative;bottom:1px" src="https://static.igem.org/mediawiki/2013/d/d5/PB_handresults.gif"/> | + | <img width="70px" style="margin-left:120px;margin-right:15px;position:relative;bottom:1px" src="https://static.igem.org/mediawiki/2013/d/d5/PB_handresults.gif"/>Results page |
</div> | </div> | ||
</a> | </a> | ||
Revision as of 09:25, 4 October 2013
FIGHT TUBERCULOSIS WITH MODERN WEAPONS
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb) that affects nearly two billion people around the world. On this website we present four new ways to use the power of synthetic biology in the fight against TB.
A biosensor that detects the presence of sequence specific antibiotic resistance genes.
A safe and specific high-throughput drug screening method that targets essential mycobacterial metabolic proteins.
A phage system with low fitness cost producing sRNA, which inhibit the synthesis of antibiotic resistance proteins.
Infiltrate macrophages with an E.coli producing TDMH, an enzyme that will lyse the Mycobacteria cell wall.
Results page
Centre for Research and Interdisciplinarity (CRI)
Faculty of Medicine Cochin Port-Royal, South wing, 2nd floor
Paris Descartes University
24, rue du Faubourg Saint Jacques
75014 Paris, France
+33 1 44 41 25 22/25
team2013@igem-paris.org
+33 1 44 41 25 22/25
team2013@igem-paris.org 
